Plasma volume expansion with Haemaccel does not impair haemostasis during reduction mammaplasty

South African Journal of Surgery

Volumn 36, Issue 1, 1998, Pages 22-26

  Van Wyk, Veronica ^a   Marais, Alta ^a   Diedericks, Johann ^a   Van Der Walt, Efraim ^a   Dumas, Leon ^a   Badenhorst, Philip N ^a   Alexander, Kim C ^a   Kotzé, Harry F ^a  

^a UNIVERSITY OF THE FREE STATE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; COLLAGEN; FIBRINOGEN; PLASMA SUBSTITUTE; POLYGELINE; PROTHROMBIN; RINGER LACTATE SOLUTION; THROMBIN; THROMBOPLASTIN;

ADULT; ANESTHESIA; ARTICLE; BLEEDING TIME; BLOOD EXAMINATION; BLOOD OXYGEN TENSION; BLOOD PRESSURE; BREAST REDUCTION; CLINICAL ARTICLE; CLINICAL TRIAL; COLLOID; CONTROLLED STUDY; CRYSTALLOID; DOSE TIME EFFECT RELATION; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMODILUTION; HEMOSTASIS; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; INTRAVENOUS DRUG ADMINISTRATION; PARTIAL THROMBOPLASTIN TIME; PLASMA VOLUME; PROTHROMBIN TIME; PULSE RATE; SURGICAL PATIENT; THROMBIN TIME; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT;

ADULT; ANALYSIS OF VARIANCE; FEMALE; HEMOSTASIS; HUMANS; ISOTONIC SOLUTIONS; MAMMAPLASTY; PLASMA SUBSTITUTES; POLYGELINE; SINGLE-BLIND METHOD;

EID: 0031955851     PISSN: 00382361     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Nearman HS, Herman ML. Toxic effects of colloids in the intensive care unit. In: Blumer JL, Randall Bond G, eds. Critical Care Clinics: Toxic Effects of Drugs Used in the ICU. Philadelphia: WB Saunders, 1991: 713-723.
2. Weinstein PD, Doerfler ME. Systemic complications of fluid resuscitation. In: Kaufman BS, ed. Fluid Resuscitation of the Critically Ill. Critical Care Clinics. Philadelphia: WB Saunders, 1992: 439-448.
3. Fischer M. The effect of different plasma volume expanders (Rheomacrodex and Haemaccel) on the fibrinolytic system and some platelet functions. Modified gelatins as plasma substitutes. Bibl Haematol 1969; 33: 457-465.
4. Eichler J, Stephan G. The effect of plasma substitutes on coagulation. Modified gelatins as plasma substitutes. Bibl Haematol 1969; 33: 452-456.
5. Heene DL, Lasch HG. The effect of gelatine plasma substitutes on the hemostatic mechanism. Modified gelatins as plasma substitutes. Bibl Haematol 1969; 33: 428-433.
6. Poliwoda H. The effect of plasma expanders on the formation of platelet-rich agglutination thrombi. Modified gelatins as plasma substitutes. Bibl Haematol 1969, 33: 466-471.
7. Holst J, Lindblad B, Mátzsch T, Bergqvist D. Effect on primary haemostasis of prophylactic regimens of low molecular weight heparin, unfractionated heparin, dextran and their combinations. An animal experimental study. Thromb Res 1992; 65: 651-656.
8. Evans PA, Garnett M, Boffard K, Kirkman E, Jacobson BF. Evaluation of the effect of colloid (Haemaccel) on the bleeding time in the trauma patient. J R Soc Med 1996; 89: 101-104.
9. Marcel GA, Sabatier C, Galbrun M, Caspar C. Etude des effects sur I'aggregation plaquettaire de quatre solutés de remplissage a base de gélatines fluides. Nouv Presse Méd 1974; 3: 2260-2271.
10. Stibbe J, Van de Plas PM, Ong GL, et al. Effects of the gelatine plasma substitutes Haemaccel, Plasmagel and Plasmion (Geloplasma) on collagen-ADP and adrenaline-induced aggregation of human platelets in vitro. Haemostasis 1981; 10: 276-288.
11. Migne J, Saint-Maurice JP, Santona R, Kunz S. Gélatines fluides modifiées et aggregations plaquettaires in vivo chez l'homme. Anest Analg Réanim 1976; 33: 577-584.
12. Ruttman TG, James MFM, Viljoen JF. Haemodilution induces hypercoagulable state. Br J Anaesth 1996; 76: 412-414.
13. Mardel SN, Saunders F, Ollerenshaw L, Edwards C, Baddeley D. Reduced quality of in-vitro clot formation with gelatin-based plasma substitutes. Lancet 1996; 347: 825.
14. Robbins TH. A reduction mammaplasty with the areola-nipple based on an inferior dermal pedicle. Plast Reconstr Surg 1977, 59: 64-67.
15. Brozovic M, Mackie I. Investigation of acute haemostatic failure. In: Dacie JV, Lewis SM, eds. Practical Haematology. London: Churchill Livingstone, 1991: 279-292.
16. Hoffman JJM, Verhappen MAL. Automated nephelometry of fibrinogen: Analytical performance and observations during thrombolytic therapy. Clin Chem 1988; 34: 2135-2140.
17. Van Wyk V, Heyns A du P. Low molecular weight heparin as an anticoagulant for in vitro platelet function studies. Thromb Res 1990; 57: 601-609.
18. Lind SE. The bleeding time does not predict surgical bleeding. J Am Soc Hematol 1991; 77: 2547-2552.
19. Rodgers RPC, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost 1990; 16: 1-20.
20. Arnaud CD. Mineral and bone homeostasis. In: Wyngaarden JB, Smith LH, eds. Cecil Textbook of Medicine. Philadelphia: WB Saunders, 1988: 1469-1481.